Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07173985 · ClinicalTrials.gov registry record · NA
Strategies for Optimizing a Mailed FIT Program in Appalachia
A NA study of Colonic Neoplasms, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT07173985: Recruiting NA study of Colonic Neoplasms, sponsored by Ohio State University Comprehensive Cancer Center.
NCT07173985 is a NA study of Colonic Neoplasms that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 500 participants, below the 1,487-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07173985, a NA study of Colonic Neoplasms, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study is examining strategies for optimizing mailed fecal immunochemical test (FIT) programs. In doing so, it will assess the efficacy of two promising strategies, FIT kit materials and patient navigation delivery mode. These strategies may help to improve colorectal cancer screening rates.
Primary Outcome
Proportion of participants who return of a completed FIT kit
Conditions Studied
Interventions
- BEHAVIORAL Standard FIT kit
- BEHAVIORAL Enhanced FIT kit
- BEHAVIORAL Telephone patient navigation
- BEHAVIORAL Text message patient navigation
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2026-01-20 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
What NCT07173985 shows while recruiting
NCT07173985 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,487-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Colonic Neoplasms appearing as the primary indexed condition, and to 4 interventions - of which Standard FIT kit is the first listed.
NCT07173985 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07173985 about?
NCT07173985 is a clinical study titled "Strategies for Optimizing a Mailed FIT Program in Appalachia". The proposed study is examining strategies for optimizing mailed fecal immunochemical test (FIT) programs. In doing so, it will assess the efficacy of two promising strategies, FIT kit materials and patient navigation delivery mode. These strategies may help to improve colorectal cancer screening ra...
What is the current status of trial NCT07173985?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2026-01-20. Estimated completion is 2028-07-31.
What conditions does trial NCT07173985 study?
This clinical trial studies the following conditions: Colonic Neoplasms.
What interventions are being tested in trial NCT07173985?
The interventions under investigation include: Standard FIT kit (BEHAVIORAL), Enhanced FIT kit (BEHAVIORAL), Telephone patient navigation (BEHAVIORAL), Text message patient navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT07173985?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07173985 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonic Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07173985's enrollment target sits among peer trials
500 7th of 14 higher than 8 of 14 other Colonic Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colonic Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
RECRUITING · NA
-
Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer
RECRUITING · NA
-
Japanese National Computed Tomographic (CT) Colonography Trial
COMPLETED · NA
-
Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System
COMPLETED · NA
-
Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening
COMPLETED · NA
-
Case Series With Saneso 3600 Colonoscope
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI